Bharat Biotech Ltd (BBL) on Monday claimed to have launched the country’s first indigenously developed cell culture H1N1 swine flu vaccine under the brand name HNVAC. In a statement, the Hyderabad-based biotechnology firm claimed that the vaccine was the only developing world flu vaccine to be manufactured in cell culture, a highly sterile and controlled manufacturing process, instead of eggs. Bharat Biotech received the approval from the Drugs Controller General of India earlier this month to launch the vaccine.“Our goal right now is get the flu vaccine easily accessible,” chairman, Dr Krishna Ella, said.